U.S. Urology Partners is expanding. With the backing of NMS Capital, the physician management company has added Syracuse, New York-based Associated Medical Professionals of New York for an undisclosed sum. Associated Medical Professionals of New York is a multi-specialty medical practice with two locations in Syracuse and Ellinwood. It has 25 urologists, three radiation oncologists and an extensive support staff. This add-on deal extends the reach of U.S. Urology Partners into central New York State and more than doubles its physician count. The combined groups will benefit from U.S. Urology Partners’ substantial investment in people, technology and services to better address patient and employee needs in the communities they serve, while being well-positioned for continued growth. 

This deal is actually the first add-on acquisition for U.S. Urology Partners, according to search results in the HealthCare Deal Database. The group provides management expertise and infrastructure resources across important functional areas, including provider recruitment, payor contracting, data analytics and compliance.

NMS Capital formed the group in December 2018 when it acquired Central Ohio Urology Group for an undisclosed amount. At the time of the deal, Central Ohio Urology Group was a 27-physician group that provided a full suite of urological services and others, including men’s health, women’s health and cancer care. It had 18 locations in central Ohio and a single-specialty ambulatory surgery center.

The merger with Associated Medical Professionals of New York will create one of the nation’s leading independent providers of urological and other specialty services. The only other comparable group would be Solaris Health, which was formed through the merger of Integrated Medical Professionals and The Urology Group by Lee Equity Partners in a deal valued at $240 million. Solaris Health has 120 physicians. It seems like competition in the urology space will be heating up as both groups have indicated future expansions are in the pipeline.